Markku Kupari

11.3k total citations · 3 hit papers
202 papers, 8.2k citations indexed

About

Markku Kupari is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Markku Kupari has authored 202 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 144 papers in Cardiology and Cardiovascular Medicine, 47 papers in Pulmonary and Respiratory Medicine and 39 papers in Surgery. Recurrent topics in Markku Kupari's work include Cardiovascular Function and Risk Factors (53 papers), Cardiac Valve Diseases and Treatments (34 papers) and Cardiac Imaging and Diagnostics (28 papers). Markku Kupari is often cited by papers focused on Cardiovascular Function and Risk Factors (53 papers), Cardiac Valve Diseases and Treatments (34 papers) and Cardiac Imaging and Diagnostics (28 papers). Markku Kupari collaborates with scholars based in Finland, United States and United Kingdom. Markku Kupari's co-authors include Pekka Koskinen, Magnus Lindroos, Juhani Heikkilä, Jyri Lommi, Reijo S. Tilvis, Jukka Lehtonen, Riina Kandolin, Heikki Turto, Juha Virolainen and P. Hekali and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Markku Kupari

194 papers receiving 7.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevalence of aortic valve abnormalities in the elderly: An echocardiographic study of a random population sample

1993 821 citations Markku Kupari et al. profile →
Cardiac Sarcoidosis

2014 379 citations Riina Kandolin, Jukka Lehtonen et al. Circulation profile →
Cardiac sarcoidosis: phenotypes, diagnosis, treatment, and prognosis

2023 90 citations Jukka Lehtonen, Valtteri Uusitalo et al. European Heart Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Markku Kupari Finland	47	5.3k	2.2k	1.7k	1.4k	1.2k	202	8.2k
Keld E. Sørensen Denmark	33	8.6k 1.6×	2.7k 1.2×	1.9k 1.1×	2.2k 1.6×	1.4k 1.1×	94	12.2k
Akira Yamashina Japan	46	6.9k 1.3×	1.8k 0.8×	1.2k 0.7×	1.7k 1.2×	764 0.6×	281	9.7k
Shunichi Homma United States	49	4.9k 0.9×	1.3k 0.6×	1.0k 0.6×	1.3k 1.0×	1.1k 0.9×	193	8.1k
Yoshihiro Fukumoto Japan	49	3.6k 0.7×	2.4k 1.1×	1.5k 0.9×	1.7k 1.2×	627 0.5×	309	8.6k
Carmel M. McEniery United Kingdom	54	9.0k 1.7×	2.7k 1.2×	1.2k 0.7×	1.6k 1.1×	658 0.5×	183	12.2k
Masatsugu Hori Japan	53	3.6k 0.7×	1.0k 0.5×	678 0.4×	1.7k 1.2×	1.0k 0.8×	197	8.2k
Vojtěch Melenovský Czechia	47	8.8k 1.7×	2.0k 0.9×	924 0.5×	1.5k 1.1×	700 0.6×	228	11.2k
Yasuki Kihara Japan	48	5.9k 1.1×	1.1k 0.5×	1.0k 0.6×	2.2k 1.6×	823 0.7×	446	10.3k
Masakazu Yamagishi Japan	49	4.8k 0.9×	2.0k 0.9×	1.4k 0.8×	4.6k 3.3×	1.4k 1.1×	428	11.8k
Patrick Lacolley France	51	6.2k 1.2×	1.7k 0.8×	1.3k 0.7×	1.5k 1.1×	556 0.4×	172	9.7k

Countries citing papers authored by Markku Kupari

Since Specialization

Citations

This map shows the geographic impact of Markku Kupari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markku Kupari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markku Kupari more than expected).

Fields of papers citing papers by Markku Kupari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markku Kupari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markku Kupari. The network helps show where Markku Kupari may publish in the future.

Co-authorship network of co-authors of Markku Kupari

This figure shows the co-authorship network connecting the top 25 collaborators of Markku Kupari. A scholar is included among the top collaborators of Markku Kupari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markku Kupari. Markku Kupari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pöyhönen, Pauli, Riina Kandolin, & Markku Kupari. (2025). Cardiovascular magnetic resonance in the assessment of the risk of fatal or life-threatening ventricular arrhythmias in suspected vs diagnosed cardiac sarcoidosis. European Heart Journal. 46(46). 5092–5093.

Pöyhönen, Pauli, Jukka Lehtonen, Suvi Syväranta, et al.. (2024). Magnetic Resonance Imaging in the Assessment of the Risk of Sudden Death in Cardiac Sarcoidosis: What Is Extensive or Significant Late Gadolinium Enhancement?. Circulation Arrhythmia and Electrophysiology. 18(1). e013239–e013239. 6 indexed citations

Pöyhönen, Pauli, Mikko I. Mäyränpää, Hanna‐Kaisa Nordenswan, et al.. (2023). Cardiac magnetic resonance in histologically proven eosinophilic myocarditis. Journal of Cardiovascular Magnetic Resonance. 25(1). 79–79. 4 indexed citations

Pöyhönen, Pauli, Hanna‐Kaisa Nordenswan, Jukka Lehtonen, et al.. (2023). Cardiac magnetic resonance in giant cell myocarditis: a matched comparison with cardiac sarcoidosis. European Heart Journal - Cardiovascular Imaging. 24(4). 404–412. 17 indexed citations

Nordenswan, Hanna‐Kaisa, Pauli Pöyhönen, Jukka Lehtonen, et al.. (2022). Incidence of Sudden Cardiac Death and Life-Threatening Arrhythmias in Clinically Manifest Cardiac Sarcoidosis With and Without Current Indications for an Implantable Cardioverter Defibrillator. Circulation. 146(13). 964–975. 49 indexed citations

Nordenswan, Hanna‐Kaisa, Jukka Lehtonen, Kaj Ekström, et al.. (2021). Manifestations and Outcome of Cardiac Sarcoidosis and Idiopathic Giant Cell Myocarditis by 25‐Year Nationwide Cohorts. Journal of the American Heart Association. 10(6). e019415–e019415. 33 indexed citations

Kandolin, Riina, Jukka Lehtonen, Juhani Airaksinen, et al.. (2015). Usefulness of Cardiac Troponins as Markers of Early Treatment Response in Cardiac Sarcoidosis. The American Journal of Cardiology. 116(6). 960–964. 45 indexed citations

Kahlos, Katriina, Maija Halme, Anu Turpeinen, et al.. (2013). Keuhkovaltimoiden verenpainetauti ja krooninen tromboembolinen keuhkoverenpainetauti : harvinaiset, mutta tärkeät kohonneen keuhkoverenpaineen aiheuttajat. 68(40). 2515–2520. 1 indexed citations

Helske, Satu, Tatu A. Miettinen, Helena Gylling, et al.. (2008). Accumulation of cholesterol precursors and plant sterols in human stenotic aortic valves. Journal of Lipid Research. 49(7). 1511–1518. 40 indexed citations

10.

Helske, Satu, Petri T. Kovanen, Ken A. Lindstedt, et al.. (2007). Increased Circulating Concentrations and Augmented Myocardial Extraction of Osteoprotegerin in Heart Failure Due to Left Ventricular Pressure Overload. European Journal of Heart Failure. 9(4). 357–363. 43 indexed citations

11.

Kupari, Markku & Pekka Koskinen. (2007). Alcohol, Cardiac Arrhythmias and Sudden Death. Novartis Foundation symposium. 216. 68–85. 45 indexed citations

12.

Lilleberg, Jyrki, et al.. (2006). Duration of the Haemodynamic Action of a 24-h Infusion of Levosimendan in Patients with Congestive Heart Failure. European Journal of Heart Failure. 9(1). 75–82. 99 indexed citations

13.

Kupari, Markku, Tomi S. Mikkola, Heikki Turto, Jyri Lommi, & Olavi Ylikorkala. (2005). Vasoactive Intestinal Peptide—Release from the Heart and Response in Heart Failure Due to Left Ventricular Pressure Overload. European Journal of Heart Failure. 8(4). 361–365. 7 indexed citations

14.

Kupari, Markku, Heikki Turto, Jyri Lommi, Markku Mäkijärvi, & Hannu Parikka. (2005). Transcardiac Gradients of N-Terminal B-Type Natriuretic Peptide in Aortic Valve Stenosis. European Journal of Heart Failure. 7(5). 809–814. 15 indexed citations

15.

Kupari, Markku, Heikki Turto, & Jyri Lommi. (2005). Left ventricular hypertrophy in aortic valve stenosis: preventive or promotive of systolic dysfunction and heart failure?. European Heart Journal. 26(17). 1790–1796. 158 indexed citations

16.

Kupari, Markku, Tomi S. Mikkola, Heikki Turto, & Jyri Lommi. (2004). Is the Pregnancy Hormone Relaxin an Important Player in Human Heart Failure?. European Journal of Heart Failure. 7(2). 195–198. 25 indexed citations

17.

Kupari, Markku, et al.. (2004). Cardiac Involvement in Mulibrey Nanism: Characterization with Magnetic Resonance Imaging. Journal of Cardiovascular Magnetic Resonance. 6(3). 645–652. 12 indexed citations

18.

White, Perrin C., Aarno Hautanen, & Markku Kupari. (1998). Aldosterone synthase (CYP11B2) polymorphisms and cardiovascular function. Endocrine Research. 24(3-4). 797–804. 16 indexed citations

19.

Lommi, Jyri, Kari Pulkki, Pekka Koskinen, et al.. (1997). Haemodynamic, neuroendocrine and metabolic correlates of circulating cytokine concentrations in congestive heart failure. European Heart Journal. 18(10). 1620–1625. 67 indexed citations

20.

Kupari, Markku. (1983). Reproducibility of the systolic time intervals: effect of the temporal range of measurements. Cardiovascular Research. 17(6). 339–343. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact